Search results for "EFT"

showing 10 items of 904 documents

Effect of partial and full correction of corneal spherical aberration on visual acuity and contrast sensitivity

2008

A 60-year-old white man had cataract surgery with an AcrySof IQ intraocular lens (IOL) implanted in the right eye and a Tecnis IOL implanted in the left eye. The ocular spherical aberration (SA) target for a 6.0 mm pupil was +0.10 microm for the right eye and 0 microm for the left eye. After surgery, the ocular SA in the right eye was significantly higher than that in the left eye (+0.112 microm +/- 0.002 [SD] versus +0.021 +/- 0.003 microm; P.001). No between-eye difference in the best corrected visual acuity and photopic contrast sensitivity was found. The contrast sensitivity was significantly better in the eye with the AcrySof IQ IOL at 12 and 18 cpd under mesopic conditions. The best c…

Malemedicine.medical_specialtyVisual acuityPseudophakiagenetic structuresmedicine.medical_treatmentmedia_common.quotation_subjectVisual AcuityIntraocular lensPupilContrast SensitivityCorneaLens Implantation IntraocularOphthalmologyCorneamedicineHumansContrast (vision)media_commonPhacoemulsificationbusiness.industryMiddle AgedCataract surgeryRefractive Errorseye diseasesSensory SystemsOphthalmologyLeft eyeSpherical aberrationmedicine.anatomical_structureSurgerysense organsmedicine.symptombusinessJournal of Cataract and Refractive Surgery
researchProduct

Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.

2017

Abstract Introduction and objectives Heart failure with preserved ejection fraction and reduced ejection fraction share a high mortality risk. However, differences in the rehospitalization burden over time between these 2 entities remains unclear. Methods We prospectively included 2013 consecutive patients discharged for acute heart failure. Of these, 1082 (53.7%) had heart failure with preserved ejection fraction and 931 (46.2%) had heart failure with reduced ejection fraction. Cox and negative binomial regression methods were used to evaluate the risks of death and repeat hospitalizations, respectively. Results At a median follow-up of 2.36 years (interquartile range: 0.96-4.65), 1018 pat…

Malemedicine.medical_specialtyanimal structures030204 cardiovascular system & hematologyPatient Readmission03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineCost of IllnessInterquartile rangeRecurrenceInternal medicinemedicineHumans030212 general & internal medicineAgedHeart FailureEjection fractionbusiness.industryStroke VolumeGeneral Medicinemedicine.diseaseConfidence intervalHospitalizationHeart failureAcute DiseaseCardiologyFemalebusinessHeart failure with preserved ejection fractionRevista espanola de cardiologia (English ed.)
researchProduct

Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction

2017

Abstract Objectives The study sought to assess the outcome of percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) in patients with low left ventricular ejection fraction (LVEF) (≤35%). Background Data regarding the outcome of PCI in patients with low LVEF affected by CTO are scarcely reported. Methods The authors performed a prospective longitudinal multicenter study including consecutive patients undergoing elective PCI of CTOs. Patients were subdivided into 3 groups: group 1 (LVEF ≥50%), group 2 (LVEF 35% to 50%), and group 3 (LVEF ≤35%). Results A total of 839 patients (mean 64.6 ± 10.5 years of age, 87.7% men) underwent CTO PCI attempts. Baseline LVEF ≤35% was pr…

Malemedicine.medical_specialtyanimal structuresTime Factorsmedicine.medical_treatment610 Medicine & healthKaplan-Meier Estimate030204 cardiovascular system & hematologyCoronary AngiographyDisease-Free SurvivalVentricular Function Left2705 Cardiology and Cardiovascular Medicinechronic total occlusion; ischemic LV dysfunction; left ventricular ejection fraction; PCI; Cardiology and Cardiovascular Medicinechronic total occlusionischemic LV dysfunctionleft ventricular ejection fractionPCI03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineHumansIn patientcardiovascular diseases030212 general & internal medicineLongitudinal StudiesProspective Studieschronic total occlusionAgedProportional Hazards ModelsEjection fractionbusiness.industryPercutaneous coronary interventionleft ventricular ejection fractionPCIStroke VolumeRecovery of FunctionMiddle AgedSurgeryEuropeTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseCardiology10209 Clinic for CardiologyFemalebusinessCardiology and Cardiovascular Medicineischemic LV dysfunction
researchProduct

Hs-cTnT levels in professional soccer players throughout a season: No evidence of sustained cardiac damage

2015

a Research Institute of the Hospital 12 de Octubre (“i + 12”), Madrid, Spain b Research Institute “Dr. Vina Giner”, Molecular and Mitochondrial Medicine, Catholic University of Valencia San Vicente Martir, Valencia, Spain c School of Medicine, Catholic University of Valencia San Vicente Martir, Valencia, Spain d Human Performance Laboratory, MAPEI Sport Research Center, Italy e Department of Physical Education and Sports, University of Valencia, Valencia, Spain f Laboratory of Experimental Biochemistry & Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italy g Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy

Malemedicine.medical_specialtybiologybusiness.industryPhysical ExertionFootballbiology.organism_classificationVentricular Function LeftExercise; Football; Training; TroponinsCardiovascular DiseasesPhysical Conditioning AnimalTroponinsPhysical therapymedicineTrainingAnimalsMyocytes CardiacCardiology and Cardiovascular MedicinebusinessExerciseValenciaHumanitiesInternational Journal of Cardiology
researchProduct

Pheochromocytoma in the Pediatric Age Group: The Prostate—An Unusual Location

1990

AbstractPheochromocytomas of the prostate are rare, with only 3 cases in adults reported in the literature. We present the case of an 8-year-old boy with a pheochromocytoma of the prostate and a second tumor in the region of the left internal iliac artery. (J. Urol., 144: 1219–1221, 1990)

Malemedicine.medical_specialtybusiness.industryUrologyProstatic NeoplasmsPediatric agePheochromocytomamedicine.diseaseIliac ArterySurgeryNeoplasms Multiple PrimaryPheochromocytomamedicine.anatomical_structureEl NiñoLeft internal iliac arteryProstateHypertensionHumansMedicineChildbusinessJournal of Urology
researchProduct

Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

2020

Abstract Background Carbohydrate antigen 125 (CA125) and B-type natriuretic peptides are surrogate markers of congestion in patients with acute heart failure (AHF). The aim of the study was to assess the association between CA125 and NT-proBNP and congestion parameters in patients with AHF. Methods and results Prospective multicentre observational study that included 191 patients hospitalised for AHF. We recorded the presence of pleural effusion, peripheral oedema and inferior vena cava (IVC) diameter during the first 24–48 h after admission and evaluated their independent association with CA125 concentrations and the amino-terminal fraction of pro-B-type natriuretic peptide (NT-proBNP). Th…

Malemedicine.medical_specialtyendocrine system diseasesmedicine.drug_classPleural effusionPeripheral edemaInferior vena cavaVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansIn patientProspective StudiesAgedAged 80 and overHeart FailureEjection fractionbusiness.industryStroke VolumeMiddle AgedPrognosismedicine.diseasePeptide Fragmentsmedicine.veinHeart failureCardiologySerum ca125Femalemedicine.symptombusinessBiomarkersMedicina Clínica (English Edition)
researchProduct

Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction: a pilot study

2020

Altres ajuts: Conselleria d'Educació, Investigació, Cultura i Esport GV/2018/116 Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a therapeutic target for reducing plasma low-density lipoprotein cholesterol. Beyond lipid control, recent findings suggest a deleterious effect of this protein in the pathogenesis of postmyocardial infarction left ventricle remodelling and heart failure-related complications. The aim of this study was to assess the relationship between circulating PCSK9 and 6 month cardiac magnetic resonance imaging-derived left ventricular ejection fraction (LVEF) after a first ST-segment elevation myocardial infarction (STEMI). We prospectively evaluated 40…

Malemedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemLeft ventricular ejection fractionCardiac magnetic resonancemedicine.medical_treatmentMyocardial InfarctionInfarctionAngiotensin-Converting Enzyme InhibitorsPilot Projects030204 cardiovascular system & hematologyVentricular Function LeftPCSK9Angiotensin Receptor Antagonists03 medical and health sciences0302 clinical medicineCardiac magnetic resonance imagingOriginal Research ArticlesInternal medicinemedicineST‐segment elevation myocardial infarctionHumansST segmentOriginal Research Article030212 general & internal medicineMyocardial infarctioncardiovascular diseasesAgedKillip classEjection fractionmedicine.diagnostic_testbusiness.industryPercutaneous coronary interventionStroke VolumeMiddle Agedmedicine.diseaseST-segment elevation myocardial infarctionlcsh:RC666-701Heart failureCardiologyST Elevation Myocardial InfarctionProprotein Convertase 9Cardiology and Cardiovascular Medicinebusiness
researchProduct

Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhan…

2013

Background: Contrast echocardiography improves accuracy and reduces interreader variability on left ventricular (LV)functional analyses inthe settingof two-dimensional (2D) echocardiography. Theneedfor contrast imaging using three-dimensional (3D) echocardiography is less defined. The aim of this multicenter study was to define the accuracy and interreader agreement of unenhanced and contrast-enhanced 2D and 3D echocardiography for the assessment of LV volumes and ejection fraction (EF). Methods: A multicenter, open-label study was conducted including 63 patients, using intrasubject comparisons to assess the agreement of unenhanced and contrast-enhanced 2D and 3D echocardiography as well as…

Malemedicine.medical_specialtymedia_common.quotation_subjectEchocardiography Three-DimensionalSulfur HexafluorideContrast MediaMagnetic Resonance Imaging CineSensitivity and SpecificityVentricular Dysfunction LeftCardiac magnetic resonance imagingInternal medicinemedicineContrast (vision)HumansRadiology Nuclear Medicine and imagingSingle-Blind MethodRadionuclide VentriculographyPhospholipidsmedia_commonObserver VariationEjection fractionmedicine.diagnostic_testbusiness.industryReproducibility of ResultsThree dimensional echocardiographyStroke VolumeOrgan SizeConfidence intervalEuropeContrast echocardiographyCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceNuclear medicine3d echocardiographyJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Fatal Anaphylactic Shock Ceftriaxone-Induced in a 4-Year-Old Child

2014

One of the most used cephalosporin in clinical practice is ceftriaxone. Anaphylaxis due to the administration of ceftriaxone is considered a rare event. Here, we report a case of fatal anaphylactic shock after the administration of ceftriaxone in a child who had tolerated the drug in past exposures. The allergic pathogenesis is sustained by the clinical data (short time between the inoculation of the drug and the onset of the symptoms; past exposure to the same molecule and probable sensitization) and the postmortem examination findings (polivisceral congestion and intense eosinophilia found in the histological examination).

Malemedicine.medical_specialtymedicine.drug_classCephalosporinDrug Hypersensitivity03 medical and health sciencesFatal Outcome0302 clinical medicineHumansMedicineEosinophilia030216 legal & forensic medicineAnaphylaxisSensitizationRetrospective StudiesHistological examination030201 allergybusiness.industryCeftriaxoneRetrospective cohort studyGeneral Medicinemedicine.diseaseDermatologyAnti-Bacterial Agentsmedicine.anatomical_structureChild PreschoolPediatrics Perinatology and Child HealthEmergency MedicineCeftriaxoneAnaphylactic shockAutopsymedicine.symptombusinessAnaphylaxismedicine.drugPediatric Emergency Care
researchProduct

Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes

2009

Background The N-terminal portion of brain natriuretic peptide (NT-proBNP) has been identified as an indicator of prognosis in different cardiovascular diseases. The objective of this study was to determine the utility of measuring plasma NT-proBNP levels in patients with acute coronary syndromes. Methods and results We studied 66 patients admitted in our division for acute coronary syndromes. Patients underwent a venous blood sample within 24 h from the admission to determine NT-proBNP levels. Increasing plasma levels of NT-proBNP (in tertiles) was associated with a greater history of hypertension and current smoking, whereas biochemical parameters were associated with higher level of crea…

Malemedicine.medical_specialtymedicine.drug_classCreatineRisk AssessmentVentricular Dysfunction Leftchemistry.chemical_compoundPredictive Value of TestsRecurrenceNt-proBNP N-terminal pro-B-type natriuretic peptide acute coronary sydromeInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideCreatine Kinase MB FormHumansIn patientHospital MortalityAcute Coronary SyndromeAgedInpatientsCreatininebiologybusiness.industryTroponin IGeneral MedicineLength of StayMiddle AgedPrognosisBrain natriuretic peptidePeptide FragmentschemistryCreatininePredictive value of testsCardiologybiology.proteinFemaleCreatine kinaseN terminal pro b type natriuretic peptideCardiology and Cardiovascular MedicinebusinessBiomarkersCoronary Artery Disease
researchProduct